{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T02:04:55Z","timestamp":1789265095124,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,12]]},"DOI":"10.7759\/cureus.116153","type":"journal-article","created":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T01:19:59Z","timestamp":1789262399000},"source":"Crossref","is-referenced-by-count":0,"title":["Intravitreal Anti-vascular Endothelial Growth Factor Injection Practices Among Indonesian Vitreoretinal Specialists: Findings From a 2021 National Survey"],"prefix":"10.7759","author":[{"given":"Andrea","family":"Silitonga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna Tabita Hasianna","family":"Silitonga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rova","family":"Virgana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Iskandar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arief","family":"Kartasasmita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grimaldi","family":"Ihsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Made","family":"Indra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000399","article-title":"Intravitreal injection technique and monitoring: updated guidelines of an expert panel","volume":"34 Suppl 12","author":"Avery RL","year":"2014","unstructured":"Avery RL, Bakri SJ, Blumenkranz MS, et al.. Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina. 2014, 34 Suppl 12:S1-S18. 10.1097\/IAE.0000000000000399","journal-title":"Retina"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000486145","article-title":"2018 update on intravitreal injections: Euretina expert consensus recommendations","volume":"239","author":"Grzybowski A","year":"2018","unstructured":"Grzybowski A, Told R, Sacu S, Bandello F, Moisseiev E, Loewenstein A, Schmidt-Erfurth U. 2018 update on intravitreal injections: Euretina expert consensus recommendations. Ophthalmologica. 2018, 239:181-93. 10.1159\/000486145","journal-title":"Ophthalmologica"},{"key":"ref3","article-title":"Intravitreal injection therapy","author":"Royal College of Ophthalmologists","year":"2018","unstructured":"Royal College of Ophthalmologists. Ophthalmic Service Guidance: Intravitreal injection therapy. Royal College of Ophthalmologists, London, UK; 2018. https:\/\/curriculum.rcophth.ac.uk\/wp-content\/uploads\/2018\/02\/Intravitreal-Injection-Therapy-August-2018-2.pdf."},{"key":"ref4","unstructured":"Guidelines of Intravitreal Injections of Avastin (Bevacizumab). (2016). Accessed. June 9, 2021: https:\/\/www.vrsi.in\/wp-content\/uploads\/2023\/06\/Avastin_Guidlines_Book.pdf."},{"key":"ref5","article-title":"Intravitreal injection guidelines","volume":"33","author":"Rishi E","year":"2015","unstructured":"Rishi E, Bansal P. Intravitreal injection guidelines. Sci J Med Vis Res Foun. 2015, 33:80-2.","journal-title":"Sci J Med Vis Res Foun"},{"key":"ref6","article-title":"Intravitreal injection: technique and safety","volume":"4","author":"Lai TY","year":"2015","unstructured":"Lai TY, Liu S, Das S, Lam DSC. Intravitreal injection: technique and safety. Asia Pac J Ophthalmol (Phila. 2015, 4:321-8.","journal-title":"Asia Pac J Ophthalmol (Phila"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S77067","article-title":"Global reported endophthalmitis risk following intravitreal injections of anti-VEGF: a literature review and analysis","volume":"9","author":"Sigford DK","year":"2015","unstructured":"Sigford DK, Reddy S, Mollineaux C, Schaal S. Global reported endophthalmitis risk following intravitreal injections of anti-VEGF: a literature review and analysis. Clin Ophthalmol. 2015, 9:773-81. 10.2147\/OPTH.S77067","journal-title":"Clin Ophthalmol"},{"key":"ref8","article-title":"Survey of intravitreal injection practice patterns among retina specialists","volume":"60","author":"Sassalos TM","year":"2020","unstructured":"Sassalos TM, Patel N, Andrews C, et al.. Survey of intravitreal injection practice patterns among retina specialists. J Vitreoretin Dis. 2020, 60:306-11.","journal-title":"J Vitreoretin Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2019.03.023","article-title":"Real-world trends in intravitreal injection practices among American retina specialists","volume":"3","author":"Chaturvedi R","year":"2019","unstructured":"Chaturvedi R, Wannamaker KW, Riviere PJ, Khanani AM, Wykoff CC, Chao DL. Real-world trends in intravitreal injection practices among American retina specialists. Ophthalmol Retina. 2019, 3:656-62. 10.1016\/j.oret.2019.03.023","journal-title":"Ophthalmol Retina"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2019.03.013","article-title":"Current practice preferences and safety protocols for intravitreal injection of anti-vascular endothelial growth factor agents","volume":"3","author":"Uhr JH","year":"2019","unstructured":"Uhr JH, Xu D, Rahimy E, Hsu J. Current practice preferences and safety protocols for intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmol Retina. 2019, 3:649-55. 10.1016\/j.oret.2019.03.013","journal-title":"Ophthalmol Retina"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S117801","article-title":"Practice patterns of ophthalmologists administering intravitreal injections in Europe: a longitudinal survey","volume":"10","author":"Huang K","year":"2016","unstructured":"Huang K, Sultan MB, Zhou D, Tressler CS, Mo J. Practice patterns of ophthalmologists administering intravitreal injections in Europe: a longitudinal survey. Clin Ophthalmol. 2016, 10:2485-8. 10.2147\/OPTH.S117801","journal-title":"Clin Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2014.03.009","article-title":"Survey of intravitreal injection techniques and treatment protocols among retina specialists in Canada","volume":"49","author":"Xing L","year":"2014","unstructured":"Xing L, Dorrepaal SJ, Gale J. Survey of intravitreal injection techniques and treatment protocols among retina specialists in Canada. Can J Ophthalmol. 2014, 49:261-6. 10.1016\/j.jcjo.2014.03.009","journal-title":"Can J Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S285955","article-title":"Survey of intravitreal injection techniques among retina specialists in Mexico","volume":"14","author":"Henaine-Berra A","year":"2020","unstructured":"Henaine-Berra A, Flores-Peredo V, Lopezcarasa-Hernandez G, Martinez-Castellanos MA, Mira-Lorenzo X, Solis-Vivanco A, Garcia-Aguirre G. Survey of intravitreal injection techniques among retina specialists in Mexico. Clin Ophthalmol. 2020, 14:4089-98. 10.2147\/OPTH.S285955","journal-title":"Clin Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1602_19","article-title":"All India Ophthalmological Society members' survey: practice pattern of intravitreal anti-vascular endothelial growth factor injection","volume":"68","author":"Sundar D","year":"2020","unstructured":"Sundar D, Das T, Chhablani J, Kumar A, Sharma N. All India Ophthalmological Society members' survey: practice pattern of intravitreal anti-vascular endothelial growth factor injection. Indian J Ophthalmol. 2020, 68:1095-8. 10.4103\/ijo.IJO_1602_19","journal-title":"Indian J Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5935\/0004-2749.20150009","article-title":"Survey: technique of performing intravitreal injection among members of the Brazilian Retina and Vitreous Society (SBRV)","volume":"78","author":"Shiroma HF","year":"2015","unstructured":"Shiroma HF, Farah ME, Takahashi WY, Gomes AM, Goldbaum M, Rodrigues EB. Survey: technique of performing intravitreal injection among members of the Brazilian Retina and Vitreous Society (SBRV). Arq Bras Oftalmol. 2015, 78:32-5. 10.5935\/0004-2749.20150009","journal-title":"Arq Bras Oftalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aew305","article-title":"Glycaemic control during cataract surgery under loco-regional anaesthesia: a growing problem and we are none the wiser","volume":"117","author":"Kumar CM","year":"2016","unstructured":"Kumar CM, Seet E, Eke T, Dhatariya K, Joshi GP. Glycaemic control during cataract surgery under loco-regional anaesthesia: a growing problem and we are none the wiser. Br J Anaesth. 2016, 117:687-91. 10.1093\/bja\/aew305","journal-title":"Br J Anaesth"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.22608\/APO.2018136","article-title":"Asia-Pacific technology and trend survey 2016-2017","volume":"8","author":"Chhablani J","year":"2019","unstructured":"Chhablani J, Shaikh A, Goud A, et al.. Asia-Pacific technology and trend survey 2016-2017. Asia Pac J Ophthalmol (Phila). 2019, 8:43-54. 10.22608\/APO.2018136","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/opo.12217","article-title":"A survey of UK practice patterns in the delivery of intravitreal injections","volume":"35","author":"Samia-Aly E","year":"2015","unstructured":"Samia-Aly E, Cassels-Brown A, Morris DS, Stancliffe R, Somner JE. A survey of UK practice patterns in the delivery of intravitreal injections. Ophthalmic Physiol Opt. 2015, 35:450-4. 10.1111\/opo.12217","journal-title":"Ophthalmic Physiol Opt"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8567912","article-title":"Current evidence for the prevention of endophthalmitis in anti-VEGF intravitreal injections","volume":"2018","author":"Lau PE","year":"2018","unstructured":"Lau PE, Jenkins KS, Layton CJ. Current evidence for the prevention of endophthalmitis in anti-VEGF intravitreal injections. J Ophthalmol. 2018, 2018:8567912. 10.1155\/2018\/8567912","journal-title":"J Ophthalmol"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1097\/00006982-200410001-00002","article-title":"Evolving guidelines for intravitreous injections","volume":"24","author":"Aiello LP","year":"2004","unstructured":"Aiello LP, Brucker AJ, Chang S, et al.. Evolving guidelines for intravitreous injections. Retina. 2004, 24:3-19.","journal-title":"Retina"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.12489","article-title":"Safety, sterility and stability of direct-from-vial multiple dosing intravitreal injection of bevacizumab","volume":"43","author":"Das T","year":"2015","unstructured":"Das T, Volety S, Ahsan SM, et al.. Safety, sterility and stability of direct-from-vial multiple dosing intravitreal injection of bevacizumab. Clin Exp Ophthalmol. 2015, 43:466-73. 10.1111\/ceo.12489","journal-title":"Clin Exp Ophthalmol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000008","article-title":"Endophthalmitis associated with intravitreal injections: office-based setting and operating room setting","volume":"34","author":"Tabandeh H","year":"2014","unstructured":"Tabandeh H, Boscia F, Sborgia A, et al.. Endophthalmitis associated with intravitreal injections: office-based setting and operating room setting. Retina. 2014, 34:18-23. 10.1097\/IAE.0000000000000008","journal-title":"Retina"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2014.04.029","article-title":"Predictors of sustained intraocular pressure elevation in eyes receiving intravitreal anti-vascular endothelial growth factor therapy","volume":"158","author":"Yannuzzi NA","year":"2014","unstructured":"Yannuzzi NA, Patel SN, Bhavsar KV, Sugiguchi F, Freund KB. Predictors of sustained intraocular pressure elevation in eyes receiving intravitreal anti-vascular endothelial growth factor therapy. Am J Ophthalmol. 2014, 158:319-327.e2. 10.1016\/j.ajo.2014.04.029","journal-title":"Am J Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/468993-intravitreal-anti-vascular-endothelial-growth-factor-injection-practices-among-indonesian-vitreoretinal-specialists-findings-from-a-2021-national-survey","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T01:20:01Z","timestamp":1789262401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/468993-intravitreal-anti-vascular-endothelial-growth-factor-injection-practices-among-indonesian-vitreoretinal-specialists-findings-from-a-2021-national-survey"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.116153","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,12]]}}}